1. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group;Sanz;Blood,1999
2. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo Coco;N. Engl. J. Med.,2013
3. Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors;Avvisati;Semin. Hematol.,2001
4. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups;Sanz;Blood,2000